Sun Pharmaceutical Industries Ltd (SUNPHARMA) — Announcement | 28 September 2026
Sun Pharma announced a global licensing deal with LIB Therapeutics for lerodalcibep, a PCSK9 inhibitor approved in the EU, granting Sun exclusive rights outside the US and China. The agreement provides access to a $3.7 billion market growing at 38% CAGR and includes upfront payments, milestones, and royalties. This expands Sun's innovative medicines portfolio in cardiovascular care, targeting a large unmet patient need.
About Sun Pharmaceutical Industries Ltd (SUNPHARMA)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when SUNPHARMA files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track SUNPHARMA — Free💡 Ask AI about this filing
📊 More SUNPHARMA filings
- 🟡 Shareholding Pattern — 26 September 2026Sun Pharmaceutical Industries announced that shareholders approved reclassifying the promoter group ...
- Announcement — 25 September 2026Sun Pharmaceutical announces that its trading window will close on 1 October 2026 and remain shut un...
- 🔴 Announcement — 22 September 2026Sun Pharmaceutical Industries Limited presented its investor outlook for FY26, highlighting a divers...
- 🔴 Announcement — 11 September 2026Sun Pharmaceutical announced a confidential settlement with a plaintiff in the In re Generic Pharmac...
- 🔴 Announcement — 9 September 2026Sun Pharmaceutical announced the incorporation of a wholly owned subsidiary, Sun Pharma Global Treas...
🔥 Also filed on 28 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when SUNPHARMA files new disclosures
Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track SUNPHARMA — FreeFree account · 2 AI queries/day